Note 12 - Segment Information
|12 Months Ended|
Jun. 30, 2019
|Notes to Financial Statements|
|Segment Reporting Disclosure [Text Block]||
The Company has
tworeportable segments based on the nature of its products; they are Protein Sciences and Diagnostics and Genomics.
The Company's Protein Sciences segment is comprised of the Reagent Sol
utions and the Analytical Solutions operating segment. These businesses manufacture consumables used for conducting laboratory experiments by both industry and academic scientists within the biotechnology and biomedical life science fields.,
customer in the Protein Sciences segment accounted for more than
10%of the segment’s net sales for the years ended
June 30, 2019
The Company's Diagnostics and Genomics is comprised of the Diagnostics, Genomics, and Exosome operating segments. The Diagnostics division consists of the Diagnostics operating segment and develops and manufactures a range of controls and calibrators used with diagnostic equipment and as proficiency testing tools, as well as other reagents incorporated into diagnostic kits, and the Genomics division consists of the Genomics and Exosome operating segments and sells a portfolio of clinical molecular diagnostic oncology assays, as well as tissue-based in-situ hybridization assays for research in clinical use.
customer in the Diagnostics and Genomics segment accounted for more than
10%of the segment’s net sales for the fiscal years ended
June 30, 2019,
noconcentrations of business transacted with a particular customer or supplier or concentrations of revenue from a particular product or geographic area that would severely impact the Company in the near term.
Following is financial information relating to the operating segments (in thousands):
The Company has some integrated facilities that serve multiple segments. As such, asset and capital expenditure information by reportable segment has
notbeen provided and is
notavailable, since the Company does
notproduce or utilize such information internally. In addition, although depreciation and amortization expense is a component of each reportable segment’s operating results, it is
The Company has disclosed sales by geographic area based on the location of the customer or distributor in Noteissagregated product and service revenue by consumables, instruments, and services in Note
2.The Company has disclosed d
2.The Company considers total instrument and total service revenue to represent similar groups of products in the fiscal years presented. The Company considered our consumables sold in the Protein Sciences and Diagnostics and Genomics segments to represent different groups of products and therefore have separately disclosed the related consumables revenue (in thousands) :
The following is financial information relating to geographic areas (in thousands):
Long-lived assets are comprised of land, buildings and improvements and equipment, net of accumulated depreciation and other assets.
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef